Fulcrum Therapeutics Inc. (FULC)
3.21
-0.03 (-0.93%)
At close: Mar 04, 2025, 11:53 AM
Fulcrum Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 25.56M | 35.1M | 35.41M | 57.05M | 96.71M | 72.8M | 407K |
| Short-Term Investments | 210.66M | 167.82M | 182.75M | 55.86M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | n/a |
| Other Long-Term Assets | 3.1M | 2.1M | 542K | 7.17M | -78.68M | 38K | 60K |
| Receivables | 2.25M | 1.08M | 4.11M | 2.71M | 111K | 501K | 39K |
| Inventory | n/a | -852K | -473K | -2.78M | 2.98M | 559K | 734K |
| Other Current Assets | 3.73M | 3.52M | 3.73M | 3.89M | 3.26M | 797K | 892K |
| Total Current Assets | 242.2M | 207.52M | 226M | 112.91M | 100.08M | 74.09M | 1.34M |
| Property-Plant & Equipment | 12.39M | 15.97M | 7.37M | 8.4M | 87.94M | 10.55M | 2.94M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 15.49M | 19.17M | 9M | 16.66M | 10.36M | 11.68M | 3M |
| Total Assets | 257.69M | 226.69M | 235M | 129.58M | 110.44M | 85.77M | 4.34M |
| Account Payables | 2.76M | 3.64M | 4.79M | 4.08M | 2.19M | 1.26M | 1.67M |
| Deferred Revenue | n/a | 934K | 4.71M | 14.91M | 3.99M | 2.8M | n/a |
| Short-Term Debt | 2.19M | 5.2M | n/a | 17K | 50K | 46K | n/a |
| Other Current Liabilities | 8.73M | 6.95M | 9.7M | 7.72M | 5.92M | 2.92M | 1.11M |
| Total Current Liabilities | 13.68M | 16.73M | 19.2M | 26.73M | 12.14M | 4.23M | 2.79M |
| Long-Term Debt | 8.63M | 10.82M | n/a | n/a | n/a | n/a | 34.59M |
| Other Long-Term Liabilities | 197K | 197K | 4.26M | 4.7M | 5.13M | 5.54M | -34.35M |
| Total Long-Term Liabilities | 8.83M | 11.02M | 4.26M | 7.67M | 11.15M | 5.54M | 233K |
| Total Liabilities | 22.5M | 27.74M | 23.46M | 34.4M | 23.29M | 9.77M | 3.02M |
| Total Debt | 10.82M | 13.42M | n/a | 17K | 50K | 46K | 34.59M |
| Common Stock | 62K | 52K | 41K | 28K | 23K | 16K | 1K |
| Retained Earnings | -509.67M | -412.34M | -302.47M | -221.62M | -150.8M | -68.12M | -35.54M |
| Comprehensive Income | -136K | -797K | -397K | -2K | -110.44M | -1.96M | -893K |
| Shareholders Equity | 235.19M | 198.94M | 211.54M | 95.18M | 87.15M | 76M | 1.32M |
| Total Investments | 210.66M | 167.82M | 182.75M | 55.86M | 1.09M | 1.09M | n/a |